Phase I Study of Hemay102 in Patients With Advanced Solid Tumors

NCT03982303 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Patients With Advanced Stage Solid Tumors

Interventions

DRUG: Hemay102

Sponsor

Tianjin Hemay Oncology Pharmaceutical Co., Ltd